Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.46 | N/A |
| PEG Ratio (TTM) | -13.21 | N/A |
| P/S Ratio (TTM) | 2.18 | N/A |
| P/B Ratio (TTM) | 0.93 | N/A |
| P/FCF Ratio (TTM) | 13.69 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.52 | N/A |
| Price to 5YR AVG FCF Ratio | 16.70 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.93% | N/A |
| ROE (TTM) | 7.56% | N/A |
| Net Profit Margin (TTM) | 17.57% | N/A |
| ROIC 5YR AVG | 11.10% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.76% | 13.82% | 12.43% |
| Revenue | 6.90% | 13.39% | 12.62% |
| Net Income | -2.23% | 16.50% | 15.95% |
| Cash Flow | 123.41% | 19.86% | 63.43% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.54 | N/A |
| Quick Ratio (TTM) | 0.54 | N/A |
| D/E Ratio (TTM) | 0.22 | N/A |
| Interest Coverage (TTM) | 1.76 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.10 | N/A |
| LTL to 5YR AVG FCF | 4.90 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.33% | N/A |